Dossier
Food and Drug Administration advisory panel
Coverage of Food and Drug Administration advisory panel in the Nexus archive.
- FDA advisory panel narrowly rejects compounding of one peptide, back another
An FDA advisory panel recommended allowing compounding pharmacies to manufacture the peptide epitalon but narrowly voted against emideltide. The decision brings health secretary Robert F. Kennedy, Jr. closer to expanding access to unapproved peptides, which have gained popularity through social media influencers.